<DOC>
	<DOC>NCT00998361</DOC>
	<brief_summary>This is a perspective multicentric study for the treatment of patients aged equal or less than 60 years and submitted to an allogeneic hematopoietic stem cell transplantation from an HLA compatible related or unrelated donor because affected by resistent or refractory or relapsed after autologous stem cell transplantation Ewing Sarcoma or Soft tissues sarcoma who did not benefit from conventional therapy.</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma, Ewing</mesh_term>
	<criteria>Age 060 years. Performance status according to Karnofsky score &gt; 70% Normal liver function Normal renal function Normal cardiac function Informed consent Availability of an HLA compatible Donor Absence of at least one of the inclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Sarcoma</keyword>
	<keyword>allogeneic</keyword>
	<keyword>Hemopoietic stem cell transplant</keyword>
</DOC>